In addition, we found that the ATXN3L and JOSD2 promoter methylation levels were significantly lower in HCC tissues than that in normal tissues, despite histological grades, TP53 mutations, lymph node metastatic, genders, and years (Figures 3B,D). Here, JOSD2 is linked to hepatocellular carcinoma.